Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exposure of Salvaged Blood to Inflammation and Oxidative Stress: the Effect of Different Anticoagulant Regimes. Heparin vs Citrate in Cellsaver (HECICS).

NCT02674906 is registered in ClinicalTrials.gov with Ziekenhuis Oost-Limburg as lead sponsor.

NCT NCT02674906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02674906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exposure of Salvaged Blood to Inflammation and Oxidative Stress: the Effect of Different Anticoagulant Regimes. Heparin vs Citrate in Cellsaver (HECICS).
Lead sponsor
Ziekenhuis Oost-Limburg
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2016
Completion date
June 30, 2017
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intra operative bleeding, blood salvage